Senior man looking at female nurse helping him to wear sweater in retirement home (Maskot/Getty Images)
Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first, U.S. health officials recommended Thursday.
The newly approved vaccines are expected to be ready in the fall, a time when flu shots and updated COVID-19 shots also will be available. Those eligible for the RSV vaccine should talk with their doctor to see if it is right for them, the Centers for Disease Control and Prevention said in a statement.
The CDC said adults with chronic heart or lung disease, weakened immune systems and those living in long-term care facilities are at higher risk for the respiratory infection.
RSV, or respiratory syncytial virus, is a common cause of cold-like symptoms but it can be dangerous for infants and the elderly. A surge last year filled hospitals with wheezing children. There's no vaccine yet for kids, but one for pregnant women to prevent illness in infants may be coming too, pending approval from the Food and Drug Administration.
On Thursday, Dr. Rochelle Walensky, the outgoing CDC director, signed off on a recommendation made last week by an advisory panel of outside experts for a single dose of the vaccines made by Pfizer and GSK. The FDA approved the shots last month for adults 60 and older.
The CDC panel initially considered a stronger recommendation that everyone 65 and older get the shot. But they weakened their endorsement after several members had questions about how well it works in the feeblest of patients, whether boosters will be needed and be effective, and the cost.
Drugmaker GSK told the panel that its RSV vaccine would be between $200 and $295. Pfizer has not disclosed a price. The vaccines may hold up over multiple seasons and it’s not yet clear whether boosters will be recommended.
Others wanted a stronger endorsement for those 65 and older. Asking people to consult their doctor “is an absolute impediment" to getting more people vaccinated and an extra burden on health care providers, Robert Blancato, executive director of the National Association of Nutrition and Aging Services Programs, said Thursday.
President Joe Biden has gotten a second booster dose of the Pfizer COVID vaccine, and he used the occasion Wednesday to call on Congress to pass billions of dollars in additional funding to fight the pandemic.
Catching you up on what you need to know on March 30, 2022, with updates on what is happening in Kyiv, the FDA releases plans for a fourth dose of COVID vaccines, COVID subvariant BA.2 becomes dominant variant in the U.S., employees at Conde Nast form a union, and more.
A NASA astronaut is back on Earth after a yearlong, record-setting spaceflight. He caught a Russian ride from the International Space Station on Wednesday with two cosmonauts.
Blue Origin is gearing up for its first launch of the year, set for March 31st, but it's not the only one. NASA is also days away from making history with its first private mission to the International Space Station. Three amateur astronauts, who have each paid about $55 million for their seat, will reach the ISS and spend eight days at the off-earth outpost. Jim Cantrell, CEO and co-founder of Phantom Space, joins Cheddar News to discuss what the future of space tourism may look like.
Andrew Chanin, CEO of investment management firm ProcureAM, joined Cheddar to break down the many industries in the space economy and discuss what trends are driving the most growth. "Right now there's been so much media focus on space tourism. Why? Because last year it really debuted itself to the world," he said. "However it's less than 1 percent of the overall space economy, and there are many other parts of space which are actually driving this area."
Plastic has become the face of global pollution. To date, humans have produced 8.3 billion metric tons of it. Once discarded, plastic doesn’t biodegrade. Instead, it fragments into microplastics smaller than the size of a sesame seed and further into nanoplastics.
These tiny particles of plastic end up everywhere, deep in the ice of Antarctic glaciers or even inside our bodies.
So how much plastic is inside of us? And what does it mean for our health? Let’s find out.
Catching you up on what you Need to Know on Mar 29, 2022, with updates on the snow squall in Pennsylvania that caused a pileup killing three, the teacher's strike in Sacramento heading into week two, Walmart no longer selling tobacco products in select stores, and what meme stocks are up to this week.
Catching you up on what you Need to Know on Mar 28, 2022, with peace talks resuming in Ukraine as early as today, Colorado wildfires causing evacuations, Shanghai, China, ramping up restrictions once again, the Oscars debacle between Will Smith and Chris Rock, and more.
The U.S. market value of the plant-based food industry reached an all-time high last year. According to a new report from the Plant Based Food Association, retail sales of plant-based foods reached $7.4 billion, but questions are arising over whether the industry can sustain the levels of growth it had in the past few years. Julie Emmett, senior director of marketplace development at the Plant Based Food Association, joined Cheddar News' Closing Bell to discuss.
